BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28637725)

  • 21. Rituximab in systemic autoimmune rheumatic diseases: indications and practical use.
    Berghen N; Vulsteke JB; Westhovens R; Lenaerts J; De Langhe E
    Acta Clin Belg; 2019 Aug; 74(4):272-279. PubMed ID: 30253707
    [No Abstract]   [Full Text] [Related]  

  • 22. Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study.
    Qian G; Wang X; Patel NJ; Kawano Y; Fu X; Cook CE; Vanni KMM; Kowalski EN; Banasiak EP; Bade KJ; Srivatsan S; Williams ZK; Todd DJ; Weinblatt ME; Wallace ZS; Sparks JA
    medRxiv; 2022 Oct; ():. PubMed ID: 36324801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insights into systemic autoimmune rheumatic diseases using shared molecular signatures and an integrative analysis.
    Hudson M; Bernatsky S; Colmegna I; Lora M; Pastinen T; Klein Oros K; Greenwood CMT
    Epigenetics; 2017 Jun; 12(6):433-440. PubMed ID: 28387599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases.
    Bernatsky S; Linehan T; Hanly JG
    J Rheumatol; 2011 Aug; 38(8):1612-6. PubMed ID: 21532057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a computable phenotype to identify a transgender sample for health research purposes: a feasibility study in a large linked provincial healthcare administrative cohort in British Columbia, Canada.
    Rich AJ; Poteat T; Koehoorn M; Li J; Ye M; Sereda P; Salway T; Hogg R
    BMJ Open; 2021 Mar; 11(3):e040928. PubMed ID: 33766836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts.
    Muro Y; Nakanishi H; Katsuno M; Kono M; Akiyama M
    Clin Chim Acta; 2017 Sep; 472():1-4. PubMed ID: 28687351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada.
    Eyawo O; Hull MW; Salters K; Samji H; Cescon A; Sereda P; Lima VD; Nosyk B; Whitehurst DGT; Lear SA; Montaner JSG; Hogg RS;
    BMJ Open; 2018 Jan; 8(1):e019115. PubMed ID: 29331972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis.
    Wither J; Johnson SR; Liu T; Noamani B; Bonilla D; Lisnevskaia L; Silverman E; Bookman A; Landolt-Marticorena C
    Arthritis Res Ther; 2017 Feb; 19(1):41. PubMed ID: 28245862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with incident severe pulmonary arterial hypertension in systemic autoimmune rheumatic diseases: a nationwide study.
    Chen HH; Lin CH; Hsieh TY; Chen DY; Ying JC; Chao WC
    Rheumatology (Oxford); 2021 Nov; 60(11):5351-5361. PubMed ID: 33547781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases.
    Jorge AM; Lu N; Keller SF; Rai SK; Zhang Y; Choi HK
    J Rheumatol; 2018 Dec; 45(12):1689-1695. PubMed ID: 30173155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
    Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
    J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incremental direct medical costs of systemic lupus erythematosus patients in the years preceding diagnosis: A general population-based study.
    McCormick N; Marra CA; Sadatsafavi M; Aviña-Zubieta JA
    Lupus; 2018 Jul; 27(8):1247-1258. PubMed ID: 29665755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development, Sensibility, and Validity of a Systemic Autoimmune Rheumatic Disease Case Ascertainment Tool.
    Armstrong SM; Wither JE; Borowoy AM; Landolt-Marticorena C; Davis AM; Johnson SR
    J Rheumatol; 2017 Jan; 44(1):18-23. PubMed ID: 27803141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adiponectin Deregulation in Systemic Autoimmune Rheumatic Diseases.
    Brezovec N; Perdan-Pirkmajer K; Čučnik S; Sodin-Šemrl S; Varga J; Lakota K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between a History of Dengue Fever and the Risk of Systemic Autoimmune Rheumatic Diseases: A Nationwide, Population-Based Case-Control Study.
    Chen YW; Hsieh TY; Lin CH; Chen HM; Lin CC; Chen HH
    Front Med (Lausanne); 2021; 8():738291. PubMed ID: 34805205
    [No Abstract]   [Full Text] [Related]  

  • 36. The Corrona US registry of rheumatic and autoimmune diseases.
    Kremer JM
    Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S96-S99. PubMed ID: 27762197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining the long-term health burden and risk of sequelae for 14 foodborne infections in British Columbia, Canada: protocol for a retrospective population-based cohort study.
    Majowicz SE; Panagiotoglou D; Taylor M; Gohari MR; Kaplan GG; Chaurasia A; Leatherdale ST; Cook RJ; Patrick DM; Ethelberg S; Galanis E
    BMJ Open; 2020 Aug; 10(8):e036560. PubMed ID: 32868357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linking primary study data with administrative and claims data in a German cohort study on work, age, health and work participation: is there a consent bias?
    Stallmann C; Swart E; Robra BP; March S
    Public Health; 2017 Sep; 150():9-16. PubMed ID: 28605640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave.
    Kawano Y; Patel NJ; Wang X; Cook CE; Vanni KM; Kowalski EN; Banasiak EP; Qian G; DiIorio M; Hsu TY; Weinblatt ME; Todd DJ; Wallace ZS; Sparks JA
    Ann Rheum Dis; 2022 Dec; 81(12):1742-1749. PubMed ID: 35944947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases.
    Utiyama SR; Zenatti KB; Nóbrega HA; Soares JZ; Skare TL; Matsubara C; Muzzilo DA; Nisihara RM
    Immunol Invest; 2016 Aug; 45(6):566-73. PubMed ID: 27409579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.